Aetion
Ulka Campbell is currently the Head of Scientific Strategy at Aetion, a position held since November 2021. Prior to this role, Ulka Campbell worked at Pfizer from April 2007 to September 2021, serving as the Head of Safety Surveillance Research and previously as an Epidemiologist. Ulka Campbell holds a Doctor of Philosophy in Epidemiology from Columbia University, obtained in May 2005, and a Master of Public Health in Epidemiology from the University of Michigan, completed in May 1999. Ulka Campbell also earned a Bachelor of Science in Biology from the University of Michigan in May 1996.
This person is not in any teams
This person is not in any offices
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.